Evolent Health Inc. (NYSE: EVH)’s stock price has increased by 2.05 compared to its previous closing price of 30.19. but the company has seen a -10.54% decline in its stock price over the last five trading sessions.
Is It Worth Investing in Evolent Health Inc. (NYSE: EVH) Right Now?
while the 36-month beta value is 1.57.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
The public float for EVH is 93.07M, and currently, short sellers hold a 6.14% ratio of that floaft. The average trading volume of EVH on March 15, 2023 was 989.48K shares.
EVH’s Market Performance
EVH’s stock has seen a -10.54% decrease for the week, with a -4.91% drop in the past month and a 14.37% gain in the past quarter. The volatility ratio for the week is 4.95%, and the volatility levels for the past 30 days are at 3.66% for Evolent Health Inc. The simple moving average for the last 20 days is -8.33% for EVH stock, with a simple moving average of -2.49% for the last 200 days.
Analysts’ Opinion of EVH
Many brokerage firms have already submitted their reports for EVH stocks, with Truist repeating the rating for EVH by listing it as a “Hold.” The predicted price for EVH in the upcoming period, according to Truist is $33 based on the research report published on November 01st of the previous year 2022.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see EVH reach a price target of $40. The rating they have provided for EVH stocks is “Outperform” according to the report published on July 29th, 2022.
Guggenheim gave a rating of “Buy” to EVH, setting the target price at $43 in the report published on March 30th of the previous year.
EVH Trading at -2.59% from the 50-Day Moving Average
After a stumble in the market that brought EVH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.55% of loss for the given period.
Volatility was left at 3.66%, however, over the last 30 days, the volatility rate increased by 4.95%, as shares sank -5.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.75% upper at present.
During the last 5 trading sessions, EVH fell by -10.54%, which changed the moving average for the period of 200-days by +7.05% in comparison to the 20-day moving average, which settled at $33.52. In addition, Evolent Health Inc. saw 9.72% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EVH starting from WILLIAMS FRANK J, who sale 116,311 shares at the price of $34.62 back on Mar 07. After this action, WILLIAMS FRANK J now owns 819,812 shares of Evolent Health Inc., valued at $4,026,687 using the latest closing price.
Blackley Seth, the Chief Executive Officer of Evolent Health Inc., sale 95,055 shares at $34.62 during a trade that took place back on Mar 07, which means that Blackley Seth is holding 783,011 shares at $3,290,804 based on the most recent closing price.
Stock Fundamentals for EVH
Current profitability levels for the company are sitting at:
- +0.37 for the present operating margin
- +18.22 for the gross margin
The net margin for Evolent Health Inc. stands at -1.38. Equity return is now at value -2.60, with -1.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.10.
Conclusion
In a nutshell, Evolent Health Inc. (EVH) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
